Inhaled isoflurane versus IV propofol for sedation of ventilated ICU patients
Official title: Inhaled Sedation in Critically Ill Patients: a Multicentre Randomized Clinical Trial
Run by Instituto de Investigación Hospital Universitario La Paz · NCT07000526 · Data updated 2026-11-12
This trial will test whether inhaled isoflurane delivered through the Sedaconda ACD‑S shortens time on the ventilator compared with intravenous propofol in adults needing deep sedation and expected to require mechanical ventilation for more than 48 hours.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 620 (estimated) |
| Sponsor | Instituto de Investigación Hospital Universitario La Paz Academic / other |
| Locations | 22 sites (Orihuela, Alicante and 21 other locations) |
| Status | Recruiting |
| Started | December 15, 2025 |
| Main results expected | March 2027 |
| Study ends | December 2027 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07000526 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults on invasive mechanical ventilation who require deep sedation (RASS -3 to -5), are expected to need ventilation for more than 48 hours, and have no contraindications to isoflurane or propofol are the intended participants.
✕Probably not a fit
Patients with contraindications to either drug, those already ventilated for more than 48 hours, patients on ECMO or ECCO2R, pregnant or breastfeeding individuals, or those with acute neurological conditions or severe respiratory derangements are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, phase 4 trial assigns adult ICU patients 1:1 to inhaled isoflurane via the Sedaconda ACD‑S device or to standard intravenous propofol for deep sedation. The primary outcome is ventilator-free days at 28 days after randomization, with key secondary outcomes including ICU-free days, time to extubation after sedation withdrawal, and adequacy of sedation. Eligible patients are adults on invasive mechanical ventilation expected to need more than 48 hours of ventilation with a target RASS between -3 and -5 and without contraindications such as ECMO, pregnancy, or severe respiratory derangements. The trial emphasizes longer sedation periods to address gaps left by earlier short-duration studies of inhaled ICU sedation.
Why it matters
Potential benefit: If successful, inhaled isoflurane could reduce duration of mechanical ventilation and ICU stay, lowering complication risk and speeding patient recovery.
How similar studies have gone: Prior short-duration ICU studies have shown isoflurane to be non-inferior to propofol and have suggested it may facilitate weaning, but long-term outcomes after prolonged inhaled sedation remain largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Adult patients receiving mechanical ventilation, with an anticipated duration \>48 hours after randomization, and requiring deep sedation (target RASS between -3 and -5). Exclusion Criteria: * Contraindication to isoflurane or propofol * Patients with maternal ancestry from Venezuela, due to the potential presence of an mt-ND4 gene mutation associated with neurological injury after exposure to certain volatile anaesthetic agents * Significant air leak, defined as a leak exceeding 30% of the delivered minute ventilation * Allergy to isoflurane or propofol * Cardiopulmonary arrest * History of ventricular tachycardia or long QT syndrome * Tidal volume \< 300 mL or PaCO₂ \> 50 mmHg at the time of randomization. * Invasive mechanical ventilation for more than 48 hours at the time of randomization. * Pregnancy * Breast feeding * Acute neurological condition * Patients expected to require repeated surgical interventions during their ICU stay. * ECMO * ECCO2R * Active humidification strictly required * Neuromuscular disease or high spinal cord injury likely to prevent discontinuation of mechanical ventilation due to baseline condition * Requirement for benzodiazepine use for a specific indication * Burns * Life expectancy less than 48 hours, or patients with such a level of severity that death during the ICU stay is considered highly likely. * Any condition (e.g., blindness, deafness, dementia) or language barrier that prevents the administration of delirium or cognitive assessment scales. * Lack of informed consent
Where it's running
-
Hospital Vega Baja
Orihuela, Alicante, Spain Recruiting -
Hospital Germans Trias i Pujol
Badalona, Spain Recruiting -
Hospital Universitario de Bellvitge
Barcelona, Spain Recruiting -
Hospital Universitario Valle de Hebron
Barcelona, Spain Recruiting -
Hospital Universitario La Paz
Madrid, Spain Recruiting -
Hospital Universitario de la Princesa
Madrid, Spain Recruiting
Show 16 more locations
-
Hospital Universitario Gregorio Marañon
Madrid, Spain Recruiting -
Hospital Universitario Infanta Leonor
Madrid, Spain Recruiting -
Hospital Universitario Rey Juan Carlos
Madrid, Spain Recruiting -
Hospital Universitario Joan XXIII
Tarragona, Spain Recruiting -
Hospital Clínico Universitario de Valencia
Valencia, Spain Recruiting -
Hospital Universitario Rio Hortega
Valladolid, Spain Recruiting -
Hospital Universitario Doctor José Molina Orosa
Arrecife, Lanzarote-Canary Islands, Spain Not yet recruiting -
Hospital Galdakao-Usansolo Ospitalea
Galdakao, Vizcaya, Spain Not yet recruiting -
Hospital Universitario de Albacete
Albacete, Spain Not yet recruiting -
Hospital Universitario de Jaen
Jaén, Spain Not yet recruiting -
Hospital Arnau de Vilanova
Lleida, Spain Not yet recruiting -
Hospital Universitario de Fuenlabrada
Madrid, Spain Not yet recruiting -
Hospital Universitario Ramon y Cajal
Madrid, Spain Not yet recruiting -
Hospital Univeritario Puerta de Hierro
Madrid, Spain Not yet recruiting -
Hospital Regional Universitario de Málaga
Málaga, Spain Not yet recruiting -
Hospital Universitario de Toledo
Toledo, Spain Not yet recruiting
Study contacts
- Principal investigator: José M. Añón, MD, PhD — Hospital Universitario La Paz. IdiPAZ
- Study coordinator: José M. Añón, MD, PhD
- Email: jmaelizalde@gmail.com
- Phone: +(34) 912071307
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can a chest heart rhythm monitor help predict when ICU patients on a ventilator can breathe without the tube?
This study tests if a chest monitor that tracks heart rhythm can help predict when adults in the ICU on a ventilator will be able to breathe on their own after extubation.
-
Perioperative risks in adults with Brugada syndrome during anesthesia and related procedures
This registry follows adults with Brugada syndrome to see how often dangerous heart rhythms occur around anesthesia and up to 30 days after.
-
Neonatal Neurological Observation With Video AI
This study tests a real-time, non-contact video AI system to help monitor brain health in newborns with suspected brain injury during their hospital stay.
-
Remimazolam sedation in ICU patients on mechanical ventilation
This study tests whether using remimazolam for sedation helps mechanically ventilated ICU patients recover better compared to another sedative.
-
Sedation with dexmedetomidine, propofol, or both during cataract surgery
This project will test whether dexmedetomidine, propofol, or their combination (each given with fentanyl) provides the best sedation, safety, and surgeon satisfaction for adults having cataract surgery.
-
Light exposure during general anesthesia
This test checks whether covering patients' eyes during general anesthesia changes how much anesthetic adults (18–65) need.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.